Company: INDP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010099
Chunk: 25

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1
Chunk 25
---
INDAPTUS THERAPEUTICS, INC.

Unaudited Condensed Consolidated Balance Sheets

    March 31, 2025  
    December 31, 2024 
  
    Assets 

    Current assets: 

    Cash and cash equivalents 
    $3,891,021  
    $5,786,753 
  
    Prepaid expenses and other current assets 
     1,069,910  
     831,577 

    Total current assets 
     4,960,931  
     6,618,330 

    Non-current assets: 

    Right-of-use asset 
     58,119  
     82,175 
  
    Other assets - deposits to third parties 
     392,572  
     638,251 

    Total non-current assets 
     450,691  
     720,426 

    Total assets 
    $5,411,622  
    $7,338,756 

    Liabilities and stockholders’ equity 

    Current liabilities: 

    Accounts payable and other current liabilities 
    $2,552,379  
    $3,309,717 
  
    Operating lease liability, current portion 
     59,512  
     84,164 

    Total current liabilities 
     2,611,891  
     3,393,881 

    Commitments and contingencies (Note 7) 
     -  
     - 

    Stockholders’ equity: 

    Common stock: $0.01 par value, 200,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 16,034,444 shares issued and outstanding as of March 31, 2025 and 12,013,901 shares issued and outstanding as of December 31, 2024 
     160,344  
     120,139 
  
    Preferred stock: $0.01 par value, 5,000,000 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued or outstanding 
     -  
     - 
  
    Additional paid in capital 
     67,611,000  
     64,263,919 
  
    Accumulated deficit 
     (64,971,